Detalles de la búsqueda
1.
Expression of p53 Protein Associates with Anti-PD-L1 Treatment Response on Human-Derived Xenograft Model of GATA3/CR5/6-Negative Recurrent Nonmuscular Invasive Bladder Urothelial Carcinoma.
Int J Mol Sci
; 22(18)2021 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34576020
2.
Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.
Cancers (Basel)
; 12(5)2020 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32455829
3.
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma.
Life (Basel)
; 10(11)2020 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33238591
Resultados
1 -
3
de 3
1
Próxima >
>>